• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CD4 cell decline with didanosine and tenofovir and failure of triple nucleoside/nucleotide regimens may be related.

作者信息

Kakuda Thomas N, Anderson Peter L, Becker Stephen L

出版信息

AIDS. 2004 Dec 3;18(18):2442-4.

PMID:15622326
Abstract
摘要

相似文献

1
CD4 cell decline with didanosine and tenofovir and failure of triple nucleoside/nucleotide regimens may be related.去羟肌苷和替诺福韦导致的CD4细胞减少与三联核苷/核苷酸治疗方案的失败可能有关。
AIDS. 2004 Dec 3;18(18):2442-4.
2
Suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir.接受去羟肌苷加替诺福韦治疗的HIV感染患者CD4细胞增加未达最佳水平。
J Antimicrob Chemother. 2006 May;57(5):806-9. doi: 10.1093/jac/dkl045. Epub 2006 Mar 10.
3
Editorial comment: tenofovir nephrotoxicity--the disconnect between clinical trials and real-world practice.编者按：替诺福韦肾毒性——临床试验与现实世界实践之间的脱节
AIDS Read. 2009 Mar;19(3):118-9.
4
Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.与替诺福韦和去羟肌苷相关的近端肾小管功能障碍导致范科尼综合征和尿崩症：3例报告
AIDS Read. 2009 Mar;19(3):114-21.
5
Meeting notes from ICAAC. Tenofovir + ddI: a combination to avoid.
AIDS Clin Care. 2005 Jan;17(1):6-7.
6
Tenofovir and didanosine: a dangerous liaison.替诺福韦与去羟肌苷：危险的联合使用
AIDS Read. 2005 Aug;15(8):403-6, 413.
7
Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine.富马酸替诺福韦二吡呋酯与去羟肌苷之间的药物相互作用及药物与食物相互作用。
J Clin Pharmacol. 2005 Dec;45(12):1360-7. doi: 10.1177/0091270005281351.
8
Possible allergic cross-reaction to didanosine and tenofovir in an HIV-1-infected woman.
AIDS. 2007 May 11;21(8):1059-60. doi: 10.1097/QAD.0b013e3281053a42.
9
Adverse events experienced by three children taking tenofovir and didanosine in combination.
HIV Med. 2007 Sep;8(6):411. doi: 10.1111/j.1468-1293.2007.00497.x.
10
Editorial comment: tenofovir-related nephrotoxicity--who's at risk?编辑评论：替诺福韦相关的肾毒性——谁有风险？
AIDS Read. 2007 Feb;17(2):102-3.

引用本文的文献

1
Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-Emtricitabine.接受替诺福韦-恩曲他滨治疗的HIV阳性和阴性个体内源性三磷酸脱氧核苷池的分析
Antimicrob Agents Chemother. 2016 Aug 22;60(9):5387-92. doi: 10.1128/AAC.01019-16. Print 2016 Sep.
2
Reduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individuals.在HIV阴性个体中，替诺福韦-恩曲他滨治疗期间免疫激活降低。
J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):495-501. doi: 10.1097/QAI.0000000000000529.
3
Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patients.
在感染 HIV-1 的患者中同时给予替诺福韦酯和地达诺新时细胞内核苷酸水平。
Antimicrob Agents Chemother. 2011 Apr;55(4):1549-55. doi: 10.1128/AAC.00910-10. Epub 2011 Jan 31.
4
Model for intracellular Lamivudine metabolism in peripheral blood mononuclear cells ex vivo and in human immunodeficiency virus type 1-infected adolescents.外周血单个核细胞离体及人类免疫缺陷病毒1型感染青少年细胞内拉米夫定代谢模型
Antimicrob Agents Chemother. 2006 Aug;50(8):2686-94. doi: 10.1128/AAC.01637-05.
5
Once-daily therapies for the treatment of HIV infection.用于治疗HIV感染的每日一次疗法。
Curr HIV/AIDS Rep. 2006 Jul;3(2):86-92. doi: 10.1007/s11904-006-0023-0.